←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Viral Vectors, AAV
Phillip Zamore
PhD
🏢University of Massachusetts Chan Medical School🌐USA
Gretchen Stone Cook Chair of Biomedical Sciences; Chair, RNA Therapeutics Institute
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Phillip Zamore is a pioneer of RNA interference mechanism and co-founded Alnylam Pharmaceuticals. His work links RNA biology with AAV-delivered RNA therapeutics for cancer and genetic disease. He chairs the RNA Therapeutics Institute at UMass Chan.
Share:
🧪Research Fields 研究领域
RNAi mechanism
siRNA
AAV delivery of RNA therapeutics
piRNA
cancer RNA delivery
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Phillip Zamore 的研究动态
Follow Phillip Zamore's research updates
留下邮箱，当我们发布与 Phillip Zamore（University of Massachusetts Chan Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment